Equities

VBI Vaccines Inc

VBI Vaccines Inc

Actions
  • Price (EUR)0.0896
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-89.01%
  • Beta--
Data delayed at least 15 minutes, as of Aug 08 2024 07:34 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2463122
Total Receivables, Net1.274.131.45
Total Inventory8.506.602.58
Prepaid expenses2.282.312.37
Other current assets, total0.502.032.20
Total current assets3678130
Property, plant & equipment, net121614
Goodwill, net1.132.132.26
Intangibles, net365862
Long term investments------
Note receivable - long term------
Other long term assets1.181.361.26
Total assets87155210
LIABILITIES
Accounts payable6.43134.28
Accrued expenses6.601516
Notes payable/short-term debt000
Current portion long-term debt/capital leases51----
Other current liabilities, total129.1512
Total current liabilities763733
Total long term debt04928
Total debt514928
Deferred income tax------
Minority interest------
Other liabilities, total3.695.095.37
Total liabilities799166
SHAREHOLDERS EQUITY
Common stock454442442
Additional paid-in capital1079082
Retained earnings (accumulated deficit)(582)(490)(378)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total2821(1.57)
Total equity7.5364144
Total liabilities & shareholders' equity87155210
Total common shares outstanding248.618.61
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.